No. 9 Yayingshi Road
Science City Huangpu District
Guangzhou
China
86 20 3210 6666
https://www.yunkanghealth.com
Sector(s): Healthcare
Industry: Diagnostics & Research
Full Time Employees: 1,510
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Mr. Yong Zhang | Chairman & CEO | 285.83k | N/A | 1972 |
Mr. Yingjia Lin | CFO & Joint Company Secretary | N/A | N/A | 1980 |
Mr. Xubo Wang | Executive Vice President | N/A | N/A | 1975 |
Ms. Lok Yee Chan A.C.I.S., A.C.S. | Joint Company Secretary | N/A | N/A | 1990 |
Yunkang Group Limited operates as a medical operation service provider in the People's Republic of China. The company offers diagnostic testing services for medical institution alliances, including setting up or upgrading diagnostic centers, the establishment of standard operating procedures for diagnostic testing, diagnostic consultation and staff training, procurement of equipment, smart internet of things, and logistics assistance. It also provides diagnostic outsourcing services comprising pathology tests; infectious disease diagnostic tests, including hepatitis B virus, tuberculosis, human papilloma virus, EB virus, rabies virus, and nucleic acid tests for respiratory pathogens; genetic reproduction, and screening tests. In addition, the company offers routine diagnostic tests for chronic kidney, blood, autoimmune, endocrine metabolism, and other diseases. Further, it provides diagnostic testing services for financial institutions and insurance companies, including personalized diagnostic testing, medical report consultation, and hospital referral services; information technology, medical logistics, and medical equipment procurement; and healthcare technology development. The company provides its services through independent clinical laboratories and on-site diagnostic centers. Yunkang Group Limited was founded in 2008 and is headquartered in Guangzhou, the People's Republic of China.
Yunkang Group Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.